Table 1.
Primer | Forward Oligonucleotides | Reverse Oligonucleotides |
---|---|---|
GEF-H1 | 5′-GAGGCGCAAGAACTTGGTAG-3′ | 5′-CCATCTCGGCTTTCTGTCTC-3′ |
p115RhoGEF | 5′-CAGCTCTGAGAATGGCACTG-3′ | 5′-AGGATCGCTTCAGGGACAG-3′ |
PDZ-RhoGEF | 5′-GGGGTCCTACCCTGAAGAAG-3′ | 5′-TTCCCAGGCCTCACAGTATC-3′ |
l-Arginine | 5′-AAGTTAGAGCCCCGTGTCCT-3′ | 5′-CAGCTGCCAGAAGGAAGAAC-3′ |
ROCK-I | 5′-TGGTGAAACACCAGAAGGAGCTGA-3′ | 5′-TTGCCCGCAACTGCTCAATATCAC-3′ |
ROCK-II | 5′-TAGCGCCCTGCAAAGTTTAT-3′ | 5′-CCGAATGGACTGGTTTTGTT-3′ |
Guanine dissociation inhibitor | 5′-GCCCTGTTTTGTCTTTGCTC-3′ | 5′-TCCATACTGAGGGCAAGTCC-3′ |
Atrial natriuretic peptide | 5′-ATTGACAGGATTGGAGCCCAGAGT-3′ | 5′-TGACACACCACAAGGGCTTAGGAT-3′ |
α-Tubulin | 5′-TGTGTCTTCCATCACTGCTTCCCT-3′ | 5′-AGCAGGCATTGGTGATCTCTGCTA-3′ |
Collagen type I | 5′-TTCTCCTGGCAAAGACGGACTCAA-3′ | 5′-AGGAAGCTGAAGTCATAACCGCCA-3′ |
Collagen type III | 5′-AGCTTTGTGCAAAGTGGAACCTGG-3′ | 5′-CAAGGTGGCTGCATCCCAATTCAT-3′ |
Osteopontin | 5′-TCAGCTGGATGAACCAAGTCTGGA-3′ | 5′-ACTAGCTTGTCCTTGTGGCTGTGA-3′ |
Transforming growth factor-β | 5′-GTGCGGCAGCTGTACATTGACTTT-3′ | 5′-TGTACTGTGTGTCCAGGCTCCAAA-3′ |
MMP-1 | 5′-TTACGGCTCATGAACTGGGTCACT-3′ | 5′-GGATGTGGTGTTGTTGCACCTGTT-3′ |
MMP-2 | 5′-TCTGGTGCTCCACCACATACAACT-3′ | 5′-CTGCATTGCCACCCATGGTAAACA-3′ |
MMP-3 | 5′-AGCTGAGGACTTTCCAGGTGTTGA-3′ | 5′-ACACAGGATGCCTTCCTTGGATCT-3′ |
MMP-9 | 5′-TGAACAAGGTGGACCATGAGGTGA-3′ | 5′-TAGAGACTTGCACTGCACGGTTGA-3′ |
GAPDH | 5′-TGCATCCTGCACCACCAACTGCTT-3′ | 5′-ACAGCCTTGGCAGCACCAGTGGAT-3′ |
GEF, guaninine nucleotide exchange factor; ROCK, Rho-kinase; MMP, matrix metalloproteinase.